Paper Details

  1. Home
  2. Paper Details

[Ocular hypotensive effect of systemic beta-blockers in patients with primary glaucoma and arterial hypertension].

Author: KolbaskoA V, OnishchenkoA L, OnishchenkoE G, ZakharovaA V, ZhilinaN M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Oral selective beta-blockers significantly reduced intraocular pressure (IOP) in patients with primary open-angle glaucoma (POAG) and arterial hypertension (AH). IOP was reduced by 18.5% to 26% of baseline values after one year.
Paper Details　
Original Abstract of the Article :
AIM: to evaluate the ocular hypotensive efficacy of systemic beta-blockers in primary glaucoma patients suffering from arterial hypertension (AH). MATERIAL AND METHODS: The study included 29 patients with POAG (58 eyes) aged from 47 to 83 years. Patients with stage I-III POAG received instillations...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.17116/oftalma2017133246-50

データ提供：米国国立医学図書館（NLM）

Beta-Blockers: A Multifaceted Approach to Glaucoma Treatment

This research explores the field of ophthalmology, focusing on the use of systemic beta-blockers in patients with primary open-angle glaucoma (POAG) who also have arterial hypertension (AH). The study investigated the effectiveness of beta-blockers in lowering intraocular pressure (IOP) in these patients, aiming to provide a multi-faceted approach to managing both glaucoma and hypertension.

The Benefits of Beta-Blockers for Glaucoma and Hypertension

The study found that systemic beta-blockers, in addition to their role in controlling blood pressure, also effectively lowered IOP in POAG patients with AH. The researchers observed a significant reduction in IOP within four weeks of starting beta-blockers, and this effect was sustained over a year of treatment.

Simplifying Treatment Regimen with Beta-Blockers

These findings offer a potential solution to the challenges of polypharmacy, the use of multiple medications. By incorporating beta-blockers into the treatment plan for both glaucoma and hypertension, healthcare providers may be able to simplify the treatment regimen for these patients, reducing the potential for drug interactions and improving patient adherence.

Dr.Camel's Conclusion

This research demonstrates the effectiveness of systemic beta-blockers in lowering IOP in POAG patients with AH, suggesting a potential for simplified treatment regimens. This study underscores the importance of considering the benefits of multi-faceted treatment approaches to optimize patient outcomes.

Date :
  1. Date Completed 2018-04-02
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

28524139

DOI: Digital Object Identifier

10.17116/oftalma2017133246-50

Related Literature

Article Analysis
・Side Effects of bisoprolol
SNS
PICO Info
in preparation
Languages

Russian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.